19 reports

  • 5.2 RISK FACTORS AND COMORBIDITIES

Currently, the cost of cigarette is too low to prevent even a young guy to start smoking.

  • Asthma
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • MARKET OUTLINE

The individuals who smoke cigarettes, pipes, cigars or the individuals who are exposed to second-hand smoking are at higher risk of developing the disease.

  • Asthma
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

A significant dose response is seen in the relationship between lifetime exposure to smoking (measured in terms of pack years: one pack year is equal to ## cigarettes [one pack] smoked per day for one year) (Fukuchi et al., 2004; Zhong et al., 2007; Miravitlles et al., 2009).

  • Asthma
  • Asia
  • Europe
  • Japan
  • World
  • 4.1.1 Growing Global Spending on Medicines

Cigarette smoking may modify inflammation associated with asthma.

  • Asthma
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • RISK FACTORS AND COMORBIDITIES FOR COPD

CIGARETTE SMOKING IS THE MOST IMPORTANT RISK FACTOR FOR THE DEVELOPMENT OF COPD, AS ABOUT ##-##% OF COPD CASES ARE ATTRIBUTABLE TO SMOKING (EISNER ET AL., 2010; LAMPRECHT ET AL., 2011).

  • Asthma
  • Europe
  • World
  • Forecast
  • Social Conditions
  • 9.2.6 JAPAN

Cigarette smoking and asthma.

  • Asthma
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Asthma and COPD: An overview

cigarette smoke (passive smoking) Exposure to environmental pollutants such as dust, bush fires, and wood smoke Inhalation of allergens such as molds, pollen, and dust particles Exercise Diagnosis done by: Physical examination Lung tests Medical history PREVALENCE OF ASTHMA IN US AND EUROPE

  • Asthma
  • World
  • Market Size
  • DeVilbiss Healthcare LLC
  • Omron Corporation
  • REFERENCES

Cigarette smoking and asthma symptom severity among adult asthmatics.

  • Asthma
  • Chronic Disease
  • Pathology
  • Europe
  • ASP-3258 - DRUG PROFILE

EMAP II is upregulated in the lungs of cigarette smoked or exposed humans.

  • Asthma
  • Respiratory Treatment
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • Asthma
  • Clinical Trial
  • United States
  • Company Financials
  • GlobalData's company

Chronic Asthma Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: AUG 2016 LIST OF TABLES LIST OF FIGURES Chronic Asthma Global Clinical Trials Review, H##, 2016 outlines clinical trials in Chronic Asthma.

  • Asthma
  • Respiratory Treatment
  • Therapy
  • World
  • Product Initiative
  • Asthma
  • Clinical Trial
  • Medical Device
  • United States
  • GlobalData's company
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Smoke Cigarettes Montelukast Asthmatic Smoker Study (##-##) GDCT## NCT##, MK-##-##; 2005_##; EudraCT-2005-##-##; CTRI/ 2009/ ##/ ##; 2005-##-##; ##-## Respiratory Asthma, Chronic Asthma Completed Phase III Interventional montelukast sodium Merck &

  • Asthma
  • Respiratory Treatment
  • World
  • Product Initiative
  • Merck & Co., Inc.

The primary outcome measure is the change from baseline in the average number of cigarettes smoked per day.

  • Asthma
  • Autoimmune Disease
  • Research And Development
  • Therapy
  • Invion Limited
  • ASP-3258 - DRUG PROFILE
  • ASP-3258 - DRUG PROFILE

EMAP II IS UPREGULATED IN THE LUNGS OF CIGARETTE SMOKED OR EXPOSED HUMANS.

  • Asthma
  • Respiratory Disease
  • United States
  • Product Initiative
  • AstraZeneca PLC
  • ASP-3258 - DRUG PROFILE
  • GSK-2292767 - DRUG PROFILE

THE RESULTS DEMONSTRATED THAT INV## TREATED SMOKERS WERE MORE LIKELY TO STOP SMOKING COMPLETELY OR DRAMATICALLY REDUCE THE NUMBER OF CIGARETTES SMOKED.

  • Asthma
  • Respiratory Treatment
  • United States
  • Company
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Smoke Cigarettes Montelukast Asthmatic Smoker Study (##-##) GDCT## NCT##, MK-##-##; 2005_##; EudraCT-2005-##-##; CTRI/ 2009/ ##/ ##; 2005-##-##; ##-## Respiratory Asthma, Chronic Asthma Completed Phase III Interventional montelukast sodium Merck &

  • Asthma
  • Clinical Trial
  • Pharmaceutical
  • Respiratory Treatment
  • World
  • ASP-3258 - DRUG PROFILE
  • ASB-14780 - DRUG PROFILE

THE RESULTS DEMONSTRATED THAT INV## TREATED SMOKERS WERE MORE LIKELY TO STOP SMOKING COMPLETELY OR DRAMATICALLY REDUCE THE NUMBER OF CIGARETTES SMOKED.

  • Asthma
  • Chronic Disease
  • Pathology
  • Pharmaceutical
  • AstraZeneca PLC

(JT Group) is a tobacco company that manufactures and sells tobacco products, primarily cigarettes.

  • Asthma
  • Research And Development
  • United States
  • Company
  • Product Initiative